Literature DB >> 22707469

Carbamazepine-induced agammagloblinaemia clinically mimicking diffuse panbronchiolitis.

Chisho Hoshino1, Tadashige Hoshi.   

Abstract

The authors report the case of a 61-year-old man who presented with carbamazepine (CBZ)-related agammagloblinaemia accompanied by sinobronchial syndrome clinically mimicking diffuse panbronchiolitis (DPB). The patient's laboratory and radiographic findings improved significantly after cessation of CBZ, and administration of gammaglobulin and long-term oral macrolides therapy. In patients on long-term CBZ treatment, the physician should be aware of the possible development of secondary immunodeficiency, which can cause small airway diseases sharing common clinical features with DPB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22707469      PMCID: PMC3062875          DOI: 10.1136/bcr.11.2010.3535

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Diffuse panbronchiolitis: a treatable sinobronchial disease in need of recognition in the United States.

Authors:  Padmanabhan Krishnan; Rajeeve Thachil; Virgilio Gillego
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

2.  Prolonged survival of a bare lymphocyte syndrome type I patient with diffuse panbronchiolitis treated with erythromycin.

Authors:  A Azuma; N Keicho; H Furukawa; T Yabe; S Kudoh
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2001-10       Impact factor: 0.670

3.  B cell aplasia and hypogammaglobulinemia after carbamazepine treatment.

Authors:  Tatsuya Yamamoto; Tomoyuki Uchiyama; Hirokatsu Takahashi; Keiichi Himuro; Kazuaki Kanai; Satoshi Kuwabara
Journal:  Intern Med       Date:  2010-04-01       Impact factor: 1.271

4.  Secondary bronchiolitis obliterans organising pneumonia in a patient with carbamazepine-induced hypogammaglobulinemia.

Authors:  T Tamada; M Nara; M Tomaki; Y Ashino; T Hattori
Journal:  Thorax       Date:  2007-01       Impact factor: 9.139

5.  Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin.

Authors:  S Kudoh; A Azuma; M Yamamoto; T Izumi; M Ando
Journal:  Am J Respir Crit Care Med       Date:  1998-06       Impact factor: 21.405

Review 6.  Diffuse panbronchiolitis.

Authors:  V Poletti; G Casoni; M Chilosi; M Zompatori
Journal:  Eur Respir J       Date:  2006-10       Impact factor: 16.671

Review 7.  A review of carbamazepine's hematologic reactions and monitoring recommendations.

Authors:  J L Sobotka; B Alexander; B L Cook
Journal:  DICP       Date:  1990-12

8.  Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease.

Authors:  C M Roifman; H M Lederman; S Lavi; L D Stein; H Levison; E W Gelfand
Journal:  Am J Med       Date:  1985-08       Impact factor: 4.965

9.  Radiologic findings of adult primary immunodeficiency disorders. Contribution of CT.

Authors:  R G Obregon; D A Lynch; T Kaske; J D Newell; C H Kirkpatrick
Journal:  Chest       Date:  1994-08       Impact factor: 9.410

10.  Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis.

Authors:  H Nagai; H Shishido; R Yoneda; E Yamaguchi; A Tamura; A Kurashima
Journal:  Respiration       Date:  1991       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.